The global Bacteriophage Therapy market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Armata Pharmaceuticals, Inc.
Locus Biosciences, Inc.
Intralytix, Inc.
Eliava Biopreparations Ltd.
InnoPhage, Ltd
Pherecydes Pharma
Eligo Bioscience SA
Nextbiotics
Phagelux Inc.
TechnoPhage
Intodeworld, Inc.
Fixed-phage Ltd.
Phagomed Biopharma GmbH.
ContraFect Corporation
BiomX Ltd.
EnBiotix, Inc.
PhagePro, Inc.
Micreos BV
Phi Therapeutics
Adaptive Phage Therapeutics, Inc.
By Types:
Oral
Topical
Parenteral
By Applications:
Organ Transplantation
Bacterial Infections
Alcoholic Hepatitis
Other
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Bacteriophage Therapy Market Size Analysis from 2023 to 2028
1.5.1 Global Bacteriophage Therapy Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Bacteriophage Therapy Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Bacteriophage Therapy Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Bacteriophage Therapy Industry Impact
Chapter 2 Global Bacteriophage Therapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Bacteriophage Therapy (Volume and Value) by Type
2.1.1 Global Bacteriophage Therapy Consumption and Market Share by Type (2017-2022)
2.1.2 Global Bacteriophage Therapy Revenue and Market Share by Type (2017-2022)
2.2 Global Bacteriophage Therapy (Volume and Value) by Application
2.2.1 Global Bacteriophage Therapy Consumption and Market Share by Application (2017-2022)
2.2.2 Global Bacteriophage Therapy Revenue and Market Share by Application (2017-2022)
2.3 Global Bacteriophage Therapy (Volume and Value) by Regions
2.3.1 Global Bacteriophage Therapy Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Bacteriophage Therapy Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Bacteriophage Therapy Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Bacteriophage Therapy Consumption by Regions (2017-2022)
4.2 North America Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
4.10 South America Bacteriophage Therapy Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Bacteriophage Therapy Market Analysis
5.1 North America Bacteriophage Therapy Consumption and Value Analysis
5.1.1 North America Bacteriophage Therapy Market Under COVID-19
5.2 North America Bacteriophage Therapy Consumption Volume by Types
5.3 North America Bacteriophage Therapy Consumption Structure by Application
5.4 North America Bacteriophage Therapy Consumption by Top Countries
5.4.1 United States Bacteriophage Therapy Consumption Volume from 2017 to 2022
5.4.2 Canada Bacteriophage Therapy Consumption Volume from 2017 to 2022
5.4.3 Mexico Bacteriophage Therapy Consumption Volume from 2017 to 2022
Chapter 6 East Asia Bacteriophage Therapy Market Analysis
6.1 East Asia Bacteriophage Therapy Consumption and Value Analysis
6.1.1 East Asia Bacteriophage Therapy Market Under COVID-19
6.2 East Asia Bacteriophage Therapy Consumption Volume by Types
6.3 East Asia Bacteriophage Therapy Consumption Structure by Application
6.4 East Asia Bacteriophage Therapy Consumption by Top Countries
6.4.1 China Bacteriophage Therapy Consumption Volume from 2017 to 2022
6.4.2 Japan Bacteriophage Therapy Consumption Volume from 2017 to 2022
6.4.3 South Korea Bacteriophage Therapy Consumption Volume from 2017 to 2022
Chapter 7 Europe Bacteriophage Therapy Market Analysis
7.1 Europe Bacteriophage Therapy Consumption and Value Analysis
7.1.1 Europe Bacteriophage Therapy Market Under COVID-19
7.2 Europe Bacteriophage Therapy Consumption Volume by Types
7.3 Europe Bacteriophage Therapy Consumption Structure by Application
7.4 Europe Bacteriophage Therapy Consumption by Top Countries
7.4.1 Germany Bacteriophage Therapy Consumption Volume from 2017 to 2022
7.4.2 UK Bacteriophage Therapy Consumption Volume from 2017 to 2022
7.4.3 France Bacteriophage Therapy Consumption Volume from 2017 to 2022
7.4.4 Italy Bacteriophage Therapy Consumption Volume from 2017 to 2022
7.4.5 Russia Bacteriophage Therapy Consumption Volume from 2017 to 2022
7.4.6 Spain Bacteriophage Therapy Consumption Volume from 2017 to 2022
7.4.7 Netherlands Bacteriophage Therapy Consumption Volume from 2017 to 2022
7.4.8 Switzerland Bacteriophage Therapy Consumption Volume from 2017 to 2022
7.4.9 Poland Bacteriophage Therapy Consumption Volume from 2017 to 2022
Chapter 8 South Asia Bacteriophage Therapy Market Analysis
8.1 South Asia Bacteriophage Therapy Consumption and Value Analysis
8.1.1 South Asia Bacteriophage Therapy Market Under COVID-19
8.2 South Asia Bacteriophage Therapy Consumption Volume by Types
8.3 South Asia Bacteriophage Therapy Consumption Structure by Application
8.4 South Asia Bacteriophage Therapy Consumption by Top Countries
8.4.1 India Bacteriophage Therapy Consumption Volume from 2017 to 2022
8.4.2 Pakistan Bacteriophage Therapy Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Bacteriophage Therapy Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Bacteriophage Therapy Market Analysis
9.1 Southeast Asia Bacteriophage Therapy Consumption and Value Analysis
9.1.1 Southeast Asia Bacteriophage Therapy Market Under COVID-19
9.2 Southeast Asia Bacteriophage Therapy Consumption Volume by Types
9.3 Southeast Asia Bacteriophage Therapy Consumption Structure by Application
9.4 Southeast Asia Bacteriophage Therapy Consumption by Top Countries
9.4.1 Indonesia Bacteriophage Therapy Consumption Volume from 2017 to 2022
9.4.2 Thailand Bacteriophage Therapy Consumption Volume from 2017 to 2022
9.4.3 Singapore Bacteriophage Therapy Consumption Volume from 2017 to 2022
9.4.4 Malaysia Bacteriophage Therapy Consumption Volume from 2017 to 2022
9.4.5 Philippines Bacteriophage Therapy Consumption Volume from 2017 to 2022
9.4.6 Vietnam Bacteriophage Therapy Consumption Volume from 2017 to 2022
9.4.7 Myanmar Bacteriophage Therapy Consumption Volume from 2017 to 2022
Chapter 10 Middle East Bacteriophage Therapy Market Analysis
10.1 Middle East Bacteriophage Therapy Consumption and Value Analysis
10.1.1 Middle East Bacteriophage Therapy Market Under COVID-19
10.2 Middle East Bacteriophage Therapy Consumption Volume by Types
10.3 Middle East Bacteriophage Therapy Consumption Structure by Application
10.4 Middle East Bacteriophage Therapy Consumption by Top Countries
10.4.1 Turkey Bacteriophage Therapy Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Bacteriophage Therapy Consumption Volume from 2017 to 2022
10.4.3 Iran Bacteriophage Therapy Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Bacteriophage Therapy Consumption Volume from 2017 to 2022
10.4.5 Israel Bacteriophage Therapy Consumption Volume from 2017 to 2022
10.4.6 Iraq Bacteriophage Therapy Consumption Volume from 2017 to 2022
10.4.7 Qatar Bacteriophage Therapy Consumption Volume from 2017 to 2022
10.4.8 Kuwait Bacteriophage Therapy Consumption Volume from 2017 to 2022
10.4.9 Oman Bacteriophage Therapy Consumption Volume from 2017 to 2022
Chapter 11 Africa Bacteriophage Therapy Market Analysis
11.1 Africa Bacteriophage Therapy Consumption and Value Analysis
11.1.1 Africa Bacteriophage Therapy Market Under COVID-19
11.2 Africa Bacteriophage Therapy Consumption Volume by Types
11.3 Africa Bacteriophage Therapy Consumption Structure by Application
11.4 Africa Bacteriophage Therapy Consumption by Top Countries
11.4.1 Nigeria Bacteriophage Therapy Consumption Volume from 2017 to 2022
11.4.2 South Africa Bacteriophage Therapy Consumption Volume from 2017 to 2022
11.4.3 Egypt Bacteriophage Therapy Consumption Volume from 2017 to 2022
11.4.4 Algeria Bacteriophage Therapy Consumption Volume from 2017 to 2022
11.4.5 Morocco Bacteriophage Therapy Consumption Volume from 2017 to 2022
Chapter 12 Oceania Bacteriophage Therapy Market Analysis
12.1 Oceania Bacteriophage Therapy Consumption and Value Analysis
12.2 Oceania Bacteriophage Therapy Consumption Volume by Types
12.3 Oceania Bacteriophage Therapy Consumption Structure by Application
12.4 Oceania Bacteriophage Therapy Consumption by Top Countries
12.4.1 Australia Bacteriophage Therapy Consumption Volume from 2017 to 2022
12.4.2 New Zealand Bacteriophage Therapy Consumption Volume from 2017 to 2022
Chapter 13 South America Bacteriophage Therapy Market Analysis
13.1 South America Bacteriophage Therapy Consumption and Value Analysis
13.1.1 South America Bacteriophage Therapy Market Under COVID-19
13.2 South America Bacteriophage Therapy Consumption Volume by Types
13.3 South America Bacteriophage Therapy Consumption Structure by Application
13.4 South America Bacteriophage Therapy Consumption Volume by Major Countries
13.4.1 Brazil Bacteriophage Therapy Consumption Volume from 2017 to 2022
13.4.2 Argentina Bacteriophage Therapy Consumption Volume from 2017 to 2022
13.4.3 Columbia Bacteriophage Therapy Consumption Volume from 2017 to 2022
13.4.4 Chile Bacteriophage Therapy Consumption Volume from 2017 to 2022
13.4.5 Venezuela Bacteriophage Therapy Consumption Volume from 2017 to 2022
13.4.6 Peru Bacteriophage Therapy Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Bacteriophage Therapy Consumption Volume from 2017 to 2022
13.4.8 Ecuador Bacteriophage Therapy Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Bacteriophage Therapy Business
14.1 Armata Pharmaceuticals, Inc.
14.1.1 Armata Pharmaceuticals, Inc. Company Profile
14.1.2 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Product Specification
14.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Locus Biosciences, Inc.
14.2.1 Locus Biosciences, Inc. Company Profile
14.2.2 Locus Biosciences, Inc. Bacteriophage Therapy Product Specification
14.2.3 Locus Biosciences, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Intralytix, Inc.
14.3.1 Intralytix, Inc. Company Profile
14.3.2 Intralytix, Inc. Bacteriophage Therapy Product Specification
14.3.3 Intralytix, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Eliava Biopreparations Ltd.
14.4.1 Eliava Biopreparations Ltd. Company Profile
14.4.2 Eliava Biopreparations Ltd. Bacteriophage Therapy Product Specification
14.4.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 InnoPhage, Ltd
14.5.1 InnoPhage, Ltd Company Profile
14.5.2 InnoPhage, Ltd Bacteriophage Therapy Product Specification
14.5.3 InnoPhage, Ltd Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Pherecydes Pharma
14.6.1 Pherecydes Pharma Company Profile
14.6.2 Pherecydes Pharma Bacteriophage Therapy Product Specification
14.6.3 Pherecydes Pharma Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Eligo Bioscience SA
14.7.1 Eligo Bioscience SA Company Profile
14.7.2 Eligo Bioscience SA Bacteriophage Therapy Product Specification
14.7.3 Eligo Bioscience SA Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Nextbiotics
14.8.1 Nextbiotics Company Profile
14.8.2 Nextbiotics Bacteriophage Therapy Product Specification
14.8.3 Nextbiotics Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Phagelux Inc.
14.9.1 Phagelux Inc. Company Profile
14.9.2 Phagelux Inc. Bacteriophage Therapy Product Specification
14.9.3 Phagelux Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 TechnoPhage
14.10.1 TechnoPhage Company Profile
14.10.2 TechnoPhage Bacteriophage Therapy Product Specification
14.10.3 TechnoPhage Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Intodeworld, Inc.
14.11.1 Intodeworld, Inc. Company Profile
14.11.2 Intodeworld, Inc. Bacteriophage Therapy Product Specification
14.11.3 Intodeworld, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Fixed-phage Ltd.
14.12.1 Fixed-phage Ltd. Company Profile
14.12.2 Fixed-phage Ltd. Bacteriophage Therapy Product Specification
14.12.3 Fixed-phage Ltd. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Phagomed Biopharma GmbH.
14.13.1 Phagomed Biopharma GmbH. Company Profile
14.13.2 Phagomed Biopharma GmbH. Bacteriophage Therapy Product Specification
14.13.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 ContraFect Corporation
14.14.1 ContraFect Corporation Company Profile
14.14.2 ContraFect Corporation Bacteriophage Therapy Product Specification
14.14.3 ContraFect Corporation Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 BiomX Ltd.
14.15.1 BiomX Ltd. Company Profile
14.15.2 BiomX Ltd. Bacteriophage Therapy Product Specification
14.15.3 BiomX Ltd. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 EnBiotix, Inc.
14.16.1 EnBiotix, Inc. Company Profile
14.16.2 EnBiotix, Inc. Bacteriophage Therapy Product Specification
14.16.3 EnBiotix, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 PhagePro, Inc.
14.17.1 PhagePro, Inc. Company Profile
14.17.2 PhagePro, Inc. Bacteriophage Therapy Product Specification
14.17.3 PhagePro, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Micreos BV
14.18.1 Micreos BV Company Profile
14.18.2 Micreos BV Bacteriophage Therapy Product Specification
14.18.3 Micreos BV Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.19 Phi Therapeutics
14.19.1 Phi Therapeutics Company Profile
14.19.2 Phi Therapeutics Bacteriophage Therapy Product Specification
14.19.3 Phi Therapeutics Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.20 Adaptive Phage Therapeutics, Inc.
14.20.1 Adaptive Phage Therapeutics, Inc. Company Profile
14.20.2 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Product Specification
14.20.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Bacteriophage Therapy Market Forecast (2023-2028)
15.1 Global Bacteriophage Therapy Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Bacteriophage Therapy Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Bacteriophage Therapy Value and Growth Rate Forecast (2023-2028)
15.2 Global Bacteriophage Therapy Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Bacteriophage Therapy Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Bacteriophage Therapy Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Bacteriophage Therapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Bacteriophage Therapy Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Bacteriophage Therapy Consumption Forecast by Type (2023-2028)
15.3.2 Global Bacteriophage Therapy Revenue Forecast by Type (2023-2028)
15.3.3 Global Bacteriophage Therapy Price Forecast by Type (2023-2028)
15.4 Global Bacteriophage Therapy Consumption Volume Forecast by Application (2023-2028)
15.5 Bacteriophage Therapy Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Dec 2025 |
| Category : Telecom and IT |
Pages : 212 |
Request Sample 
Request Discount 
Inquire Before Buy
